RELEASE OF CHOLECYSTOKININ FROM RAT MIDBRAIN SLICES AND MODULATORY EFFECT OF D2 DA RECEPTOR STIMULATION

被引:24
作者
FREEMAN, AS
CHIODO, LA
LENTZ, SI
WADE, K
BANNON, MJ
机构
[1] WAYNE STATE UNIV,SCH MED,CELLULAR & CLIN NEUROBIOL PROGRAM,DETROIT,MI 48235
[2] SINAI RES INST,CTR CELL BIOL,MOLEC NEUROBIOL LAB,DETROIT,MI 48235
关键词
RELEASE; MIDBRAIN SLICE; RADIOIMMUNOASSAY; CHOLECYSTOKININ; QUINPIROLE; DOPAMINE CELL;
D O I
10.1016/0006-8993(91)90353-W
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cholecystokinin octapeptide (CCK-8) is colocalized within a majority of dopamine (DA)-containing neurons of the rat midbrain. Exogenous CCK-8 can modulate the electrophysiological activity of DA neurons, at least in part, by direct actions on the somatodendritic region of these cells. If CCK-8 is somatodendritically released from DA neurons, it may influence DA cell function as has been shown for DA itself. In the present study, radioimmunoassay was used to determine if CCK-8 is released in vitro from slices of rat midbrain under basal and depolarizing (30 mM potassium) conditions. Low levels of CCK-8 were detected in the basal incubation medium. Thirty mM potassium caused about a 3-fold increase in the release of CCK-8. This stimulated release was abolished in calcium-free medium. The D2 receptor agonist quinpirole, but not the D1 agonist SKF 38393, attenuated the potassium-stimulated release of CCK-8 but did not affect basal release. These results show that CCK-8, like DA, can be released from midbrain slices, presumably from DA/CCK-8-containing neurons. This finding is in accordance with the possibility that CCK-8 plays a role in the regulation of DA neuronal function at the level of the cell body, where it might influence the excitability of the DA cell membrane.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 51 条
[1]   DOPAMINE AUTORECEPTORS - PHARMACOLOGICAL CHARACTERIZATION BY MICROIONTOPHORETIC SINGLE CELL RECORDING STUDIES [J].
AGHAJANIAN, GK ;
BUNNEY, BS .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 297 (01) :1-7
[2]   BRAIN CCK-B RECEPTORS MEDIATE THE SUPPRESSION OF DOPAMINE RELEASE BY CHOLECYSTOKININ [J].
ALTAR, CA ;
BOYAR, WC .
BRAIN RESEARCH, 1989, 483 (02) :321-326
[3]   INFLUENCE OF MONOAMINE-OXIDASE INHIBITION ON THE RELEASE OF H-3-DOPAMINE ELICITED BY POTASSIUM AND BY AMPHETAMINE FROM THE RAT SUBSTANTIA NIGRA AND CORPUS STRIATUM [J].
ARBILLA, S ;
LANGER, SZ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1980, 311 (01) :45-52
[4]   MESOLIMBIC DOPAMINERGIC-NEURONS AND SOMATO-DENDRITIC MECHANISMS [J].
BEART, PM ;
MCDONALD, D ;
GUNDLACH, AL .
NEUROSCIENCE LETTERS, 1979, 15 (2-3) :165-170
[5]   THE DISTRIBUTION OF CHOLECYSTOKININ IMMUNOREACTIVITY IN THE CENTRAL NERVOUS-SYSTEM OF THE RAT AS DETERMINED BY RADIOIMMUNOASSAY [J].
BEINFELD, MC ;
MEYER, DK ;
ESKAY, RL ;
JENSEN, RT ;
BROWNSTEIN, MJ .
BRAIN RESEARCH, 1981, 212 (01) :51-57
[6]   KAINIC ACID INHIBITS CHOLECYSTOKININ RELEASE FROM RAT HIPPOCAMPAL SLICES [J].
BRAY, S ;
BUSTOS, GA ;
LEE, PHK ;
HONG, JS ;
AITKEN, PG ;
NADLER, JV .
NEUROSCIENCE LETTERS, 1989, 100 (1-3) :313-318
[7]   CHOLECYSTOKININ POTENTIATES DOPAMINE-INHIBITION OF MESENCEPHALIC DOPAMINE NEURONS INVITRO [J].
BRODIE, MS ;
DUNWIDDIE, TV .
BRAIN RESEARCH, 1987, 425 (01) :106-113
[8]   PROGLUMIDE - SELECTIVE ANTAGONISM OF EXCITATORY EFFECTS OF CHOLECYSTOKININ IN CENTRAL NERVOUS-SYSTEM [J].
CHIODO, LA ;
BUNNEY, BS .
SCIENCE, 1983, 219 (4591) :1449-1450
[9]   ELECTROPHYSIOLOGICAL STUDIES ON THE SPECIFICITY OF THE CHOLECYSTOKININ ANTAGONIST PROGLUMIDE [J].
CHIODO, LA ;
FREEMAN, AS ;
BUNNEY, BS .
BRAIN RESEARCH, 1987, 410 (02) :205-211
[10]  
CHIODO LA, 1987, NEUROPHYSIOLOGY DOPA, P67